Spots Global Cancer Trial Database for nervous system neoplasms
Every month we try and update this database with for nervous system neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma | NCT01290692 | Grade IV Glioma Grade IV Astroc... Glioblastoma Mu... | TVI-Brain-1 | 18 Years - | TVAX Biomedical | |
| Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma | NCT00000689 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Methotrexate Cytarabine Leucovorin calc... Sargramostim Dexamethasone | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients | NCT01579253 | Glioblastoma Nervous System ... Central Nervous... Astrocytoma Glioma Neoplasms, Neur... Neuroectodermal... Neoplasms by Hi... Neoplasms, Nerv... | 18 Years - 75 Years | Ludwig-Maximilians - University of Munich | ||
| A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases | NCT00649207 | Brain Diseases Brain Neoplasms Central Nervous... Neoplasm Metast... Nervous System ... | ABT-888 Whole Brain Rad... | 18 Years - 99 Years | AbbVie | |
| Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients | NCT00437372 | Cancer Head and Neck C... Pelvic Cancer Nervous System ... Thoracic Neopla... | Sunitinib External Beam R... | 18 Years - | Thomas Jefferson University | |
| Protective Ventilation in Neurosurgery, a Pilot Study | NCT02450019 | Nervous System ... | Traditional to ... Protective to t... | 18 Years - 80 Years | IRCCS San Raffaele | |
| Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients | NCT00437372 | Cancer Head and Neck C... Pelvic Cancer Nervous System ... Thoracic Neopla... | Sunitinib External Beam R... | 18 Years - | Thomas Jefferson University | |
| Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients | NCT00437372 | Cancer Head and Neck C... Pelvic Cancer Nervous System ... Thoracic Neopla... | Sunitinib External Beam R... | 18 Years - | Thomas Jefferson University | |
| Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma | NCT00000689 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Methotrexate Cytarabine Leucovorin calc... Sargramostim Dexamethasone | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma | NCT01290692 | Grade IV Glioma Grade IV Astroc... Glioblastoma Mu... | TVI-Brain-1 | 18 Years - | TVAX Biomedical | |
| Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma | NCT01081223 | Glioma High Grade Astr... Glioblastoma Mu... | Cancer vaccine ... | 18 Years - | TVAX Biomedical |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
